Umberto D'Alessandro

Author PubWeight™ 206.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 2011 10.79
2 A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012 6.64
3 Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg 2006 5.91
4 In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 2010 4.25
5 History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev 2004 3.40
6 Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet 2008 3.31
7 Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ 2009 2.84
8 Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg 2006 2.79
9 Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis 2007 2.66
10 Malaria and urbanization in sub-Saharan Africa. Malar J 2005 2.56
11 Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med 2016 2.50
12 Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malar J 2006 2.48
13 Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis 2009 2.46
14 Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008. Malar J 2011 2.45
15 Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 2009 2.43
16 Forest malaria in Vietnam: a challenge for control. Am J Trop Med Hyg 2004 2.34
17 Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One 2011 2.24
18 A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood 2011 2.17
19 Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J 2009 2.13
20 Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 2009 2.05
21 Spatial targeted vector control in the highlands of Burundi and its impact on malaria transmission. Malar J 2007 1.93
22 Spatial targeted vector control is able to reduce malaria prevalence in the highlands of Burundi. Am J Trop Med Hyg 2008 1.88
23 The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004 1.86
24 Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J 2008 1.85
25 Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 2009 1.80
26 Malaria in central Vietnam: analysis of risk factors by multivariate analysis and classification tree models. Malar J 2008 1.79
27 Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J 2011 1.73
28 A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One 2010 1.72
29 Vector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case study. Malar J 2007 1.66
30 A significant increase in kdr in Anopheles gambiae is associated with an intensive vector control intervention in Burundi highlands. Trop Med Int Health 2008 1.63
31 Long-Lasting Insecticidal Hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS One 2009 1.58
32 Malaria in pregnancy: what can the social sciences contribute? PLoS Med 2007 1.56
33 Can amodiaquine be used safely during pregnancy? Lancet Infect Dis 2004 1.55
34 Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis 2012 1.53
35 Rapid decrease of malaria morbidity following the introduction of community-based monitoring in a rural area of central Vietnam. Malar J 2009 1.51
36 Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J 2006 1.50
37 Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon. Malar J 2010 1.43
38 Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg 2005 1.40
39 Case management of severe malaria--a forgotten practice: experiences from health facilities in Uganda. PLoS One 2011 1.39
40 Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg 2007 1.39
41 An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J 2012 1.39
42 High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping. Am J Trop Med Hyg 2010 1.38
43 Ranking malaria risk factors to guide malaria control efforts in African highlands. PLoS One 2009 1.38
44 Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J 2011 1.38
45 Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg 2003 1.38
46 1912-2012: a century of research on Plasmodium vivax in vitro culture. Trends Parasitol 2013 1.37
47 Low perception of malaria risk among the Ra-glai ethnic minority in south-central Vietnam: implications for forest malaria control. Malar J 2010 1.37
48 A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso. Malar J 2008 1.35
49 Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis 2014 1.34
50 Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg 2010 1.34
51 Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Trop Med Int Health 2004 1.33
52 Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections. Am J Trop Med Hyg 2005 1.31
53 Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One 2013 1.29
54 The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J 2008 1.29
55 Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Trop Med Int Health 2009 1.28
56 Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J 2012 1.27
57 Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria. Int J Parasitol 2003 1.26
58 Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study. PLoS One 2011 1.26
59 Malaria transmission and vector behaviour in a forested malaria focus in central Vietnam and the implications for vector control. Malar J 2010 1.26
60 Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Trop Med Int Health 2008 1.24
61 A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS One 2007 1.22
62 Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. Infect Genet Evol 2004 1.22
63 Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso. Am J Trop Med Hyg 2007 1.18
64 CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr 2006 1.17
65 HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis 2006 1.17
66 Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Trop Med Int Health 2004 1.16
67 Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health 2011 1.16
68 Traditional nets interfere with the uptake of long-lasting insecticidal nets in the Peruvian Amazon: the relevance of net preference for achieving high coverage and use. PLoS One 2013 1.15
69 Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials. Stat Med 2012 1.14
70 Increased risk for severe malaria in HIV-1-infected adults, Zambia. Emerg Infect Dis 2009 1.13
71 Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg 2007 1.13
72 True versus apparent malaria infection prevalence: the contribution of a Bayesian approach. PLoS One 2011 1.12
73 Malaria in pregnancy. Mediterr J Hematol Infect Dis 2013 1.11
74 A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J 2014 1.11
75 Challenges of non-commercial multicentre North-South collaborative clinical trials. Trop Med Int Health 2012 1.09
76 In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. Trans R Soc Trop Med Hyg 2005 1.08
77 The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar J 2008 1.08
78 Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso. Am J Trop Med Hyg 2012 1.07
79 The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Trop Med Int Health 2010 1.07
80 Injections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast Cambodia. PLoS One 2013 1.06
81 Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture. Int J Parasitol 2011 1.06
82 Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis 2015 1.06
83 Multiple independent introductions of Plasmodium falciparum in South America. Proc Natl Acad Sci U S A 2011 1.06
84 Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol 2003 1.05
85 Alternative treatments for indoor residual spraying for malaria control in a village with pyrethroid- and DDT-resistant vectors in the Gambia. PLoS One 2013 1.03
86 A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J 2012 1.03
87 Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg 2009 1.02
88 Social determinants of long lasting insecticidal hammock use among the Ra-glai ethnic minority in Vietnam: implications for forest malaria control. PLoS One 2012 1.02
89 Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J 2013 1.02
90 Cryopreserved reticulocytes derived from hematopoietic stem cells can be invaded by cryopreserved Plasmodium vivax isolates. PLoS One 2012 1.01
91 Bottlenecks for high coverage of intermittent preventive treatment in pregnancy: the case of adolescent pregnancies in rural Burkina Faso. PLoS One 2010 1.00
92 Malaria transmission intensity and the rate of spread of chloroquine resistant Plasmodium falciparum: Why have theoretical models generated conflicting results? Infect Genet Evol 2005 0.99
93 The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med 2015 0.99
94 Detecting Foci of Malaria Transmission with School Surveys: A Pilot Study in the Gambia. PLoS One 2013 0.98
95 Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo. Am J Trop Med Hyg 2006 0.98
96 The economic burden of malaria on the household in south-central Vietnam. Malar J 2008 0.97
97 Could the decision of trial participation precede the informed consent process? Evidence from Burkina Faso. PLoS One 2013 0.97
98 Improving malaria control in West Africa: interruption of transmission as a paradigm shift. Acta Trop 2011 0.96
99 The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia. Malar J 2009 0.96
100 Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults. Trop Med Int Health 2006 0.96
101 Marked age-dependent prevalence of symptomatic and patent infections and complexity of distribution of human Plasmodium species in central Vietnam. Am J Trop Med Hyg 2012 0.96
102 Chrysomya putoria, a putative vector of diarrheal diseases. PLoS Negl Trop Dis 2012 0.96
103 Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa. Malar J 2007 0.95
104 Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. PLoS One 2013 0.95
105 Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change. Malar J 2014 0.95
106 Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon. Malar J 2014 0.94
107 Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Stat Med 2012 0.94
108 Usefulness of the Plasmodium falciparum chloroquine resistance transporter T76 genotype failure index for the estimation of in vivo chloroquine resistance in Burkina Faso. Am J Trop Med Hyg 2005 0.94
109 Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. J Infect Dis 2003 0.94
110 Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Trop Med Int Health 2014 0.94
111 Good clinical practice in resource-limited settings: translating theory into practice. Am J Trop Med Hyg 2013 0.93
112 Malaria incidence and prevalence among children living in a peri-urban area on the coast of benin, west Africa: a longitudinal study. Am J Trop Med Hyg 2010 0.92
113 Malaria and HIV: a silent alliance. Trends Parasitol 2007 0.92
114 Does socio-economic status explain the differentials in malaria parasite prevalence? Evidence from The Gambia. Malar J 2014 0.91
115 Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malar J 2015 0.91
116 Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine (CQ)-resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high CQ resistance. Trans R Soc Trop Med Hyg 2002 0.90
117 Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Malar J 2010 0.90
118 Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure. Antimicrob Agents Chemother 2008 0.90
119 Malaria infection among pregnant women attending antenatal clinics in six Rwandan districts. Trop Med Int Health 2005 0.89
120 Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). Trop Med Int Health 2011 0.89
121 Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements. Acta Obstet Gynecol Scand 2010 0.88
122 Cost-effectiveness of long-lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam. PLoS One 2013 0.88
123 Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. Trans R Soc Trop Med Hyg 2005 0.87
124 Plasmodium knowlesi malaria in Vietnam: some clarifications. Malar J 2010 0.86
125 Development of odour-baited flytraps for sampling the African latrine fly, Chrysomya putoria, a putative vector of enteric diseases. PLoS One 2012 0.84
126 Thrombocytopenia in African children can predict the severity of malaria caused by Plasmodium falciparum and the prognosis of the disease. Am J Trop Med Hyg 2003 0.84
127 Parasite-based malaria diagnosis: are health systems in Uganda equipped enough to implement the policy? BMC Public Health 2012 0.84
128 Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa. Malar J 2009 0.84
129 Using classification tree modelling to investigate drug prescription practices at health facilities in rural Tanzania. Malar J 2012 0.84
130 Malaria Prevalence among Young Infants in Different Transmission Settings, Africa. Emerg Infect Dis 2015 0.84
131 A modified semi-nested multiplex malaria PCR (SnM-PCR) for the identification of the five human Plasmodium species occurring in Southeast Asia. Am J Trop Med Hyg 2013 0.83
132 Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis 2013 0.82
133 Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial. Trials 2014 0.81
134 The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children. Malar J 2014 0.81
135 Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey. Malar J 2014 0.81
136 Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam. Emerg Infect Dis 2015 0.79
137 Participation in medical research as a resource-seeking strategy in socio-economically vulnerable communities: call for research and action. Trop Med Int Health 2014 0.79
138 Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial. Trials 2013 0.77
139 Use of artemisinin and its derivatives for the treatment of malaria in children. Pediatr Infect Dis J 2014 0.77
140 Prenatal lipid-based nutrient supplements increase cord leptin concentration in pregnant women from rural Burkina Faso. J Nutr 2013 0.76
141 Artemisinin-Based Treatments in Pregnant Women with Malaria. N Engl J Med 2016 0.75
142 Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis 2016 0.75
143 Community sensitization and decision-making for trial participation: a mixed-methods study from The Gambia. Dev World Bioeth 2017 0.75
144 Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World. Mol Ecol 2014 0.75